The tumor-promoting effect of CYP11A1 in macrophages and tumor-suppressing effect of intratumor metyrapone administration were proposed to be due to their respective actions in driving and inhibiting glucocorticoid synthesis (20). The gene discussed is CYP11A1; the disease is neoplasm.